Mundipharma has signed an agreement to acquire all assets and rights related to antifungal candidate REZZAYO (rezafungin) from Cidara Therapeutics, including ongoing development and distribution.

director of biosimilars at Napp Pharmaceuticals. “We hope that Pelmeg will not only help to alleviate some of the resource pressures on the NHS by providing a more affordable long-acting ...